Yantai Dongcheng Pharmaceutical Group Co.,Ltd. (SHE:002675)

Market Cap	12.02B
Revenue (ttm)	2.91B
Net Income (ttm)	144.23M
Shares Out	824.60M
EPS (ttm)	0.17
PE Ratio	83.36
Forward PE	47.48
Dividend	0.06 (0.41%)
Ex-Dividend Date	May 27, 2025

Volume	6,862,783
Average Volume	10,985,734
Open	14.74
Previous Close	14.66
Day's Range	14.49 - 14.74
52-Week Range	11.33 - 16.35
Beta	0.18
RSI	51.27
Earnings Date	Aug 29, 2025

About SHE:002675

Yantai Dongcheng Pharmaceutical Group Co.,Ltd., together with its subsidiaries, engages in the manufacture and sale of biochemical APIs, finished dosage forms, nuclide drugs, and healthy products for cardiovascular, antitumor, urology, orthopedics, and other therapeutic areas. It offers heparin, chondroitin sulphate sodium and calcium, and glucosamine series products, as well as collagen, hyaluronic acid, and cytochrome C. The company also provides nadroparin calcium, hydrocortisone sodium succinate, chorionic gonadotrophin, and menotropins for...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1998
• Employees: 2,469
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002675

Financial Performance

In 2024, SHE:002675's revenue was 2.87 billion, a decrease of -12.42% compared to the previous year's 3.28 billion. Earnings were 183.83 million, a decrease of -12.35%.